Close Menu

NEW YORK (360Dx) – Health Network Laboratories announced today the acquisition of Connective Tissue Gene Tests, a molecular diagnostic laboratory specializing in inherited genetic disorders.

CTGT, founded in 2004, uses proprietary analytic methods and a mutation database to provide more than 3,000 unique tests covering 1,000 genes. The company's systems have enabled it to rapidly develop and deploy new tests, according to HNL.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.